[go: up one dir, main page]

JPS6426518A - Remedy for hyperophthalmotony - Google Patents

Remedy for hyperophthalmotony

Info

Publication number
JPS6426518A
JPS6426518A JP62183010A JP18301087A JPS6426518A JP S6426518 A JPS6426518 A JP S6426518A JP 62183010 A JP62183010 A JP 62183010A JP 18301087 A JP18301087 A JP 18301087A JP S6426518 A JPS6426518 A JP S6426518A
Authority
JP
Japan
Prior art keywords
hyperophthalmotony
remedy
bunazosin
glaucoma
bunzaosin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62183010A
Other languages
Japanese (ja)
Other versions
JP2610619B2 (en
Inventor
Akiyoshi Katou
Noritoshi Koyama
Sumio Watanabe
Yasuo Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP62183010A priority Critical patent/JP2610619B2/en
Publication of JPS6426518A publication Critical patent/JPS6426518A/en
Application granted granted Critical
Publication of JP2610619B2 publication Critical patent/JP2610619B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To obtain a remedy for hyperophthalmotony such as glaucoma, by using bunazosin which is a selective alpha1-blocker known as a hypotensor exhibiting excellent hypotensive action by oral administration. CONSTITUTION:The objective remedy for hyperophthalmotony, especially glaucoma contains bunazosin [4-amino-2-(4-butanoyl-hexahydro-1H-1,4-diazepin-1- yl)-6,7--dimethoxyquinazoline] as an active component. Bunzaosin exhibits remarkable pharmacological effect at a slight amount and suppresses ophthalmic pressure by instillation. The remedy for hyperophthalmotony is a very good drug having low stimulation and free from side effects such as pupillary contraction or toponarcosis.
JP62183010A 1987-07-22 1987-07-22 Eye drops for the treatment of ocular hypertension Expired - Lifetime JP2610619B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62183010A JP2610619B2 (en) 1987-07-22 1987-07-22 Eye drops for the treatment of ocular hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62183010A JP2610619B2 (en) 1987-07-22 1987-07-22 Eye drops for the treatment of ocular hypertension

Publications (2)

Publication Number Publication Date
JPS6426518A true JPS6426518A (en) 1989-01-27
JP2610619B2 JP2610619B2 (en) 1997-05-14

Family

ID=16128158

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62183010A Expired - Lifetime JP2610619B2 (en) 1987-07-22 1987-07-22 Eye drops for the treatment of ocular hypertension

Country Status (1)

Country Link
JP (1) JP2610619B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0728480A1 (en) * 1995-02-24 1996-08-28 Rohto Pharmaceutical Co., Ltd. Use of ifenprodil for treatment of elevated intraocular pressure
WO1997018812A1 (en) * 1995-11-17 1997-05-29 Alcon Laboratories, Inc. Combination therapy for treating glaucoma
WO2001039805A1 (en) * 1999-12-01 2001-06-07 Sankyo Company, Limited Concomitant drugs for treating glaucoma
WO2003004058A1 (en) * 2001-07-02 2003-01-16 Santen Pharmaceutical Co., Ltd. OPTIC NERVE PROTECTING AGENTS CONTAINING α1 RECEPTOR BLOCKER AS THE ACTIVE INGREDIENT

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200305424A (en) 2002-01-29 2003-11-01 Santen Pharmaceutical Co Ltd Glaucoma-treating agent comprising bunazosin and prostaglandin

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61206288A (en) * 1985-03-08 1986-09-12 松下電器産業株式会社 Flexible printed wiring substrate
JPS61166559U (en) * 1985-04-03 1986-10-16

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61206288A (en) * 1985-03-08 1986-09-12 松下電器産業株式会社 Flexible printed wiring substrate
JPS61166559U (en) * 1985-04-03 1986-10-16

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0728480A1 (en) * 1995-02-24 1996-08-28 Rohto Pharmaceutical Co., Ltd. Use of ifenprodil for treatment of elevated intraocular pressure
WO1997018812A1 (en) * 1995-11-17 1997-05-29 Alcon Laboratories, Inc. Combination therapy for treating glaucoma
WO2001039805A1 (en) * 1999-12-01 2001-06-07 Sankyo Company, Limited Concomitant drugs for treating glaucoma
EP1344535A2 (en) * 1999-12-01 2003-09-17 Sankyo Company, Limited Combined angiotensin II antagonists and adrenaline receptor blockers for treatment of glaucoma
US7307096B2 (en) 1999-12-01 2007-12-11 Sankyo Company, Limited Combined agents for treatment of glaucoma
WO2003004058A1 (en) * 2001-07-02 2003-01-16 Santen Pharmaceutical Co., Ltd. OPTIC NERVE PROTECTING AGENTS CONTAINING α1 RECEPTOR BLOCKER AS THE ACTIVE INGREDIENT
CN1302810C (en) * 2001-07-02 2007-03-07 参天制药株式会社 Optic nerve protecting agents containing alpha1 receptor blocker as the active ingredient

Also Published As

Publication number Publication date
JP2610619B2 (en) 1997-05-14

Similar Documents

Publication Publication Date Title
IE811654L (en) Ophthalmic composition
IE882442L (en) Administration of implants
EP0508488A3 (en) Use of inositol triphosphate for the treatment of diseases associated with metal intoxications
EP0489108A4 (en) Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists
IE821214L (en) Medicament
IE882391L (en) Pad printing process
KR900701323A (en) Ophthalmic preparation for the treatment of new glaucoma
NO883122L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARYLAMIDE DERIVATIVES.
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
EP0363083A3 (en) Pharmaceutical preparation for treatment of thrombocytopenic or platelet function-deficient disease
JPS6426518A (en) Remedy for hyperophthalmotony
DK0655911T3 (en) Ophthalmological preparation
ES2136686T3 (en) TREATMENT AND CONTROL OF EYE DEVELOPMENT WITH CHOLINERGIC AGONISTS.
CA2099195A1 (en) Vitreous humor tamponade for the posterior cavity in an eye
Place et al. Comparative pharmacologic effects of pilocarpine administered to normal subjects by eyedrops or by ocular therapeutic systems
EP0147185A3 (en) Therapeutic use of cytidyl disphosphocholine to increase neuronal acetylcholine
NO881768D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-DIOXANES.
TW225477B (en)
IE831551L (en) Eye ointment.
AU575892B2 (en) Tounge shaped pharmaceutical unit
NO161917C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DERIVATIVES OF TIENO AND FURO (2,3-C) PYROLES.
NO176180C (en) Analogous Process for the Preparation of New Therapeutically Active 2-Carbonyl-substituted N, N-di (trimethoxybenzoyl) piperanzines
NO166366C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOALKAN (1,2-C: 4,3-C ') DIPYRAZOLES.
NO891025D0 (en) PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTICALLY ACTIVE SIALOSYLYL GYCERIDES.
IE781283L (en) Sulphonamide-containing pharmaceutical composition

Legal Events

Date Code Title Description
R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080213

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090213

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090213

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100213

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120213

Year of fee payment: 15

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120213

Year of fee payment: 15